Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Completes SNP Assay Project with Nat'l Cancer Institute

Premium

Genotyping tools developer Sequenom, of San Diego, said it had completed a SNP assay design and validation project done in conjunction with the US National Cancer Institute.

Sequenom’s automated assay design process and MassARRAY system were used to develop more than 9,000 assays to confirm and validate SNPs in a reference population.

Following the completion of the first leg of the project, Sequenom will now aim to develop an additional set of 10,000 SNP assays for confirmation and validation.

As a result of the project, Sequenom can run high-throughput analyses on the SNPs as well as provide data and genetic information along with the company’s MassARRAY subscriptions.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.